quick search
Today:
Home Manufacturing

More Articles

VivaVision Announces Positive Topline Results from Phase 2 Trial of VVN461 for Post-Operative Inflammation Following Cataract Surgery

Dec 4, 2024

VVN461,a non-steroidal dual JAK1/TYK2 immunomodulator,achieves primary endpoint,demonstrating statistical and clinical efficacy compared to vehicle in treatingpost-operative inflammation following cat

KPS CAPITAL PARTNERS TO ACQUIRE COMPOSITES BUSINESS FROM INEOS ENTERPRISES

Dec 4, 2024

A GLOBAL LEADER IN UNSATURATED POLYESTER RESINS, VINYL ESTER RESINS AND GELCOATS NEW YORK,Dec. 3,2024-- KPS Capital Partners,LP ("KPS") announced today that,through a newly formed affiliat

Global Times: China-Laos Railway transports 43 million passengers in 3 years, acting as a new engine for regional economic development

Dec 4, 2024

BEIJING,Dec. 4,2024-- As of Monday,the China-Laos Railway has facilitated more than 43 million passenger trips and transported 48.3 million tons of goods during its three years of operation,according

Texas Cardiac Arrhythmia Institute at St. David's Medical Center first in U.S. to use FDA-approved mapping and dual energy ablation catheter

Dec 4, 2024

AUSTIN,Texas,Dec. 4,2024-- Electrophysiologists at the Texas Cardiac Arrhythmia Institute (TCAI) at St. David\'s Medical Center recently became the first in the nation to usean all-in-one high-density

Everest Medicines Announces Positive Results in Preliminary Analysis of Phase 1b/2a Clinical Trial of EVER001, a Novel BTK Inhibitor for the Treatment of Primary Membranous Nephropathy

Dec 4, 2024

Patients in the low-dose cohort who have completed 36 weeks of treatment,9 out of 11 (81.8%) achieved overall clinical remission and 10 out of 11 (91%) achieved immunological complete remission.

AV-Comparatives Announces 2024 Phishing Test Results: Avast and McAfee Excel in Yearly Assessment

Dec 4, 2024

INNSBRUCK,Austria,Dec. 3,2024-- AV-Comparatives,a leading independent organisation for IT security testing,has published the results of its comprehensive 2024 phishing protection tests. Over the year

China Tourism Group Showcases Sustainable Tourism at 'Travelogue of China' Media Tour

Dec 4, 2024

A Report From GLOBAL TIMES ONLINE: HUZHOU,China,Dec. 4,2024-- In late November,China Tourism Group showcased its sustainable tourism initiatives at the 2024 "Travelogue of China" Internation

Two Stations, One Mission: Uniting Art and Conservation in a Continuing Journey

Dec 4, 2024

《ART FOR THE EARTH: An Exhibition for Conservation》 HONG KONG,Dec. 4,2024-- Building on the success of "ART FOR THE EARTH: An Exhibition and Auction for Conservation",an initiative spearhe

Registrations now open for the 10th Goodman Magic Mile Charity Run raising funds to support Habitat for Humanity Hong Kong

Dec 4, 2024

The 10th edition ofthe Goodman Magic Mile Charity Runreturns to the Goodman Interlink facility in Tsing Yi on Sunday,9March2025

Innovent and HUTCHMED Jointly Announce NMPA Conditional Approval for TYVYT® (Sintilimab Injection) in Combination with ELUNATE® (Fruquintinib) for the Treatment of Advanced Endometrial Cancer

Dec 4, 2024

SAN FRANCISCO,U.S. andSUZHOU,China,Dec. 4,2024-- Innovent Biologics,Inc. ("Innovent") (HKEX: 01801),a world-class biopharmaceutical company that develops,manufactures and commercializes high

1 ... 64 65 66 67 68 69 70 ... 130

Quick Search

Official Affairs is a reliable source for the latest regional news, corporate updates, and official announcements, providing unbiased reporting and in-depth insights into corporate affairs.

© OfficialAffairs